P01.23 Veliparib (V) in Combination with Carboplatin/Paclitaxel (C/P)-Based Chemoradiotherapy (CRT) in Patients With Stage III NSCLC

Authors :: Bruce A. Bach
Yan Luo
Joseph K. Salama
Michael J. Guarino
Eric F. Johnson
Silpa Nuthalapati
Jared Weiss
Steven J. Feigenberg
William J. Petty
Everett E. Vokes
Jeffrey A. Bogart
James M. Larner
David Kozono
Zhaowen Sun
X. Chen
Lyudmilla Bazhenova
Lindsey Rosenwinkel
T. Stinchcombe
Thomas A. DiPetrillo
Source :: Journal of Thoracic Oncology. 16:S245
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
Veliparib
business.industry
Stage III NSCLC
Carboplatin/paclitaxel
chemistry.chemical_compound
chemistry
Internal medicine
medicine
In patient
business
Chemoradiotherapy

Full Text Access

Tools